×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中南大学 [14]
山东大学 [11]
北京大学 [8]
武汉大学 [6]
河北省人民医院 [5]
上海药物研究所 [4]
更多...
内容类型
期刊论文 [71]
会议论文 [1]
学位论文 [1]
发表日期
2021 [2]
2019 [10]
2018 [6]
2017 [7]
2016 [20]
2015 [6]
更多...
学科主题
Anesthesio... [1]
Anesthesio... [1]
Computer S... [1]
Environmen... [1]
General & ... [1]
Neuroscien... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共73条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex
期刊论文
NEUROPHARMACOLOGY, 2021, 卷号: 194, 页码: 10
作者:
Zhang, Bing
;
Yang, Xili
;
Ye, Luyu
;
Liu, Rui
;
Ye, Binglu
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2021/08/17
Structural basis of ketamine action on human NMDA receptors
期刊论文
NATURE, 2021, 卷号: 596, 期号: 7871, 页码: 301-+
作者:
Zhang, Youyi
;
Ye, Fei
;
Zhang, Tongtong
;
Lv, Shiyun
;
Zhou, Liping
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2021/11/04
Enantioselective determination of ketamine in dog plasma by chiral liquid chromatography-tandem mass spectrometry
期刊论文
BIOMEDICAL CHROMATOGRAPHY, 2019, 卷号: 33, 期号: 9, 页码: 8
作者:
Li, Ranran
;
Zhong, Kan
;
Jiang, Jinfang
;
Zhan, Yuan
;
Chen, Xiaoyan
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2020/07/01
chiral stationary phases
enantioselective LC-MS
MS
ketamine
stereoselective pharmacokinetics
Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine’s Antidepressant Effect
期刊论文
Molecular Neurobiology, 2019, 卷号: 56, 期号: 5, 页码: 3484-3500
作者:
Cui, Wenyan*
;
Ning, Yuping
;
Hong, Wu
;
Wang, Ju
;
Liu, Zhening
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
Biomarkers
Depression
Inflammation
Major depressive disorder
Treatment-resistant depression
Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects
期刊论文
The American journal of drug and alcohol abuse, 2019, 卷号: 45, 期号: 3, 页码: 276-284
作者:
Dong, Huixi
;
Yang, Cheng
;
Shen, Yidong
;
Liu, Liang
;
Liu, Mengqi
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/03
DSM-IV
ketamine
methamphetamine
psychotic disorders
psychotic symptoms
Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine
期刊论文
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2019, 卷号: 176
作者:
Xiong, Zhongwei
;
Zhang, Kai
;
Ishima, Tamaki
;
Ren, Qian
;
Ma, Min
收藏
  |  
浏览/下载:62/0
  |  
提交时间:2019/12/05
Antidepressant
Kir4.1 channel
(R)-Ketamine
Social defeat stress model
Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model
期刊论文
BEHAVIOURAL BRAIN RESEARCH, 2019, 卷号: 368
作者:
Xiong, Zhongwei
;
Fujita, Yuko
;
Zhang, Kai
;
Pu, Yaoyu
;
Chang, Lijia
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/05
(R)-ketamine
(2R,6R)-HNK
Inflammation
Bone
RANKL
Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model
期刊论文
BEHAVIOURAL BRAIN RESEARCH, 2019, 卷号: 368
作者:
Xiong, Zhongwei
;
Fujita, Yuko
;
Zhang, Kai
;
Pu, Yaoyu
;
Chang, Lijia
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
(R)-ketamine
(2R,6R)-HNK
Inflammation
Bone
RANKL
Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3 beta pathway
期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13, 页码: 501-512
作者:
Wang, Ruiwei
;
Zhang, Zihao
;
Kumar, Mukesh
;
Xu, Guangming
;
Zhang, Mengyuan
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/11
ketamine
isoflurane
neuroinflammatory
PI3K/AKT/GSK-3 beta pathway
cognitive impairment
Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway
期刊论文
Drug Design, Development and Therapy, 2019, 卷号: 13, 页码: 501-512
作者:
Wang R.
;
Zhang Z.
;
Kumar M.
;
Xu G.
;
Zhang M.
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/11
Cognitive impairment
Isoflurane
Ketamine
Neuroinflammatory
PI3K/AKT/GSK-3β pathway
©版权所有 ©2017 CSpace - Powered by
CSpace